TMTC1 Promotes Invasiveness of Ovarian Cancer Cells Through Integrins β1 and β4

Overview

Journal Cancer Gene Ther

Specialties Genetics
Oncology
Pharmacology

Date 2023 May 23

PMID 37221403

Authors

Ting-Chih Yeh

Neng-Yu Lin

Chin-Yu Chiu

Tzu-Wen Hsu

Hsin-Yi Wu

Hsuan-Yu Lin

Chi-Hau Chen

Min-Chuan Huang

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer is the most lethal gynecological malignancy and is characterized by peritoneal disseminated metastasis. Although O-mannosyltransferase TMTC1 is highly expressed by ovarian cancer, its pathophysiological role in ovarian cancer remains unclear. Here, immunohistochemistry showed that TMTC1 was overexpressed in ovarian cancer tissues compared with adjacent normal ovarian tissues, and high TMTC1 expression was associated with poor prognosis in patients with ovarian cancer. Silencing TMTC1 reduced ovarian cancer cell viability, migration, and invasion in vitro, as well as suppressed peritoneal tumor growth and metastasis in vivo. Moreover, TMTC1 knockdown reduced cell-laminin adhesion, which was associated with the decreased phosphorylation of FAK at pY397. Conversely, TMTC1 overexpression promoted these malignant properties in ovarian cancer cells. Glycoproteomic analysis and Concanavalin A (ConA) pull-down assays showed that integrins β1 and β4 were novel O-mannosylated protein substrates of TMTC1. Furthermore, TMTC1-mediated cell migration and invasion were significantly reversed by siRNA-mediated knockdown of integrin β1 or β4. Collectively, these results suggest that TMTC1-mediated invasive behaviors are primarily through integrins β1 and β4 and that TMTC1 is a potential therapeutic target for ovarian cancer.

Citing Articles

Diagnostic value of C-reactive protein/ albumin ratio and TMTC1 in intracranial atherosclerotic stenosis in patients with acute cerebral infarction.

Mo J, Liu L, Li Z, Hu Z, Tan Y, Long G Sci Rep. 2025; 15(1):8653.

PMID: 40082626 PMC: 11906579. DOI: 10.1038/s41598-025-92714-1.

Prognostic value of in pan-cancer analysis.

Zhang Y, Wu D, Yu T, Liu Y, Zhao C, Xue R Heliyon. 2024; 10(19):e38308.

PMID: 39397950 PMC: 11471174. DOI: 10.1016/j.heliyon.2024.e38308.

Protein O-mannosylation: one sugar, several pathways, many functions.

Koff M, Monagas-Valentin P, Novikov B, Chandel I, Panin V Glycobiology. 2023; 33(11):911-926.

PMID: 37565810 PMC: 10859634. DOI: 10.1093/glycob/cwad067.

References

Chen C, Wang S, Liu C, Wu Y, Wang W, Huang J . β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. Carcinogenesis. 2014; 35(6):1258-66. DOI: 10.1093/carcin/bgu007. View

Kenny H, Chiang C, White E, Schryver E, Habis M, Romero I . Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest. 2014; 124(10):4614-28. PMC: 4191043. DOI: 10.1172/JCI74778. View

Liu C, Hu R, Huang M, Lai I, Chen C, Lai H . C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity. PLoS One. 2014; 9(8):e94995. PMC: 4121071. DOI: 10.1371/journal.pone.0094995. View

Carvalho S, Oliveira T, Bartels M, Miyoshi E, Pierce M, Taniguchi N . O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer. Oncotarget. 2016; 7(40):65231-65246. PMC: 5323151. DOI: 10.18632/oncotarget.11245. View

Neubert P, Strahl S . Protein O-mannosylation in the early secretory pathway. Curr Opin Cell Biol. 2016; 41:100-8. DOI: 10.1016/j.ceb.2016.04.010. View

Choi Y, Kim B, Gao M, Kang S, Cho N . Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Biochem Biophys Res Commun. 2012; 427(3):642-8. DOI: 10.1016/j.bbrc.2012.09.114. View

Larsen I, Narimatsu Y, Clausen H, Joshi H, Halim A . Multiple distinct O-Mannosylation pathways in eukaryotes. Curr Opin Struct Biol. 2019; 56:171-178. DOI: 10.1016/j.sbi.2019.03.003. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Hang Q, Isaji T, Hou S, Zhou Y, Fukuda T, Gu J . N-Glycosylation of integrin α5 acts as a switch for EGFR-mediated complex formation of integrin α5β1 to α6β4. Sci Rep. 2016; 6:33507. PMC: 5027594. DOI: 10.1038/srep33507. View

10.

Marsico G, Russo L, Quondamatteo F, Pandit A . Glycosylation and Integrin Regulation in Cancer. Trends Cancer. 2018; 4(8):537-552. DOI: 10.1016/j.trecan.2018.05.009. View

11.

Stewart R, OConnor K . Clinical significance of the integrin α6β4 in human malignancies. Lab Invest. 2015; 95(9):976-86. PMC: 4554527. DOI: 10.1038/labinvest.2015.82. View

12.

Ahmed N, Riley C, Rice G, Quinn M . Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis. 2005; 22(5):391-402. DOI: 10.1007/s10585-005-1262-y. View

13.

Makboul R, Abdelkawi I, Badary D, Hussein M, Rhim J, Toraih E . Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity. Cells. 2021; 10(5). PMC: 8146280. DOI: 10.3390/cells10051029. View

14.

Chen C, Shyu M, Wang S, Chou C, Huang M, Lin T . MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway. Gynecol Oncol. 2015; 140(1):131-7. DOI: 10.1016/j.ygyno.2015.11.025. View

15.

Larsen I, Narimatsu Y, Joshi H, Siukstaite L, Harrison O, Brasch J . Discovery of an O-mannosylation pathway selectively serving cadherins and protocadherins. Proc Natl Acad Sci U S A. 2017; 114(42):11163-11168. PMC: 5651762. DOI: 10.1073/pnas.1708319114. View

16.

Hsu W, Che M, Liao Y, Chang H, Chen C, Huang Y . B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma. Am J Pathol. 2011; 179(3):1394-404. PMC: 3157223. DOI: 10.1016/j.ajpath.2011.05.025. View

17.

Chen X, Zhang Q, Chekouo T . Filtering High-Dimensional Methylation Marks With Extremely Small Sample Size: An Application to Gastric Cancer Data. Front Genet. 2021; 12:705708. PMC: 8313381. DOI: 10.3389/fgene.2021.705708. View

18.

Sunryd J, Cheon B, Graham J, Giorda K, Fissore R, Hebert D . TMTC1 and TMTC2 are novel endoplasmic reticulum tetratricopeptide repeat-containing adapter proteins involved in calcium homeostasis. J Biol Chem. 2014; 289(23):16085-99. PMC: 4047382. DOI: 10.1074/jbc.M114.554071. View

19.

Lee J, Ahn J, Kim T, Lee J, Choi J . Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals. Sci Rep. 2015; 5:12642. PMC: 4649895. DOI: 10.1038/srep12642. View

20.

Eisenhaber B, Sinha S, Jadalanki C, Shitov V, Tan Q, Sirota F . Conserved sequence motifs in human TMTC1, TMTC2, TMTC3, and TMTC4, new O-mannosyltransferases from the GT-C/PMT clan, are rationalized as ligand binding sites. Biol Direct. 2021; 16(1):4. PMC: 7801869. DOI: 10.1186/s13062-021-00291-w. View